NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
MUCINEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/21/2026
Trademark type
Combined
Nice classes
5
Filing date
04/15/2024
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2026-03-00
First use in commerce
2026-03-00
Drawing code
3
Owner type
16
Owner location
Parsippany, NJ, US
Examiner
FOSTER, SHATONI A
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "MUCINEX" imprinted on a three-dimensional product configuration of pink and white bi-layer tablet. The dashed lines depicting the oblong dosage tablet indicate placement of the mark on the goods and that the shape of the product is not claimed as part of the mark, and the dashed lines are not part of the mark.
Holders and representatives
Holders
RB Health (US) LLC
Representatives
Mark Lerner, Esq. DUANE MORRIS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparationspharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/30/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/30/2026
IUAF
USE AMENDMENT FILED
06/29/2026
EISU
TEAS STATEMENT OF USE RECEIVED
06/29/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/11/2025
EX2G
SOU EXTENSION 2 GRANTED
12/11/2025
EXT2
SOU EXTENSION 2 FILED
12/10/2025
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2025
EX1G
SOU EXTENSION 1 GRANTED
12/09/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/09/2025
EXT1
SOU EXTENSION 1 FILED
06/17/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2024
PUBO
PUBLISHED FOR OPPOSITION
11/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2024
DOCK
ASSIGNED TO EXAMINER
10/04/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/26/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2024
NWAP
NEW APPLICATION ENTERED
04/15/2024
Continuous trademark protection
Get notified about every new filing that threatens MUCINEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.